Patient monitoring devices market seen reaching $38.2 billion by 2030

The global patient monitoring devices market is projected to grow from $26.08 billion in 2025 to $38.2 billion by 2030, driven by chronic disease growth, telehealth adoption and demand for remote care. Asia-Pacific held the largest share in 2025, while North America ranked second.

Why it matters: - Patient monitoring devices are becoming a core part of chronic care, remote care and hospital monitoring as health systems look for earlier intervention and better outcomes. - The market's projected rise to $38.2 billion by 2030 points to sustained demand for connected healthcare tools, wearable devices and AI-enabled alerts.

What happened: - The Business Research Company released an analysis of the patient monitoring devices market on August 21, 2026. - The report said the market is expected to grow from $26.08 billion in 2025 to $28.03 billion in 2026. - The same analysis projects the market will reach $38.2 billion by 2030. - The company put the forecast growth rate at 7.5% from 2025 to 2026 and 8.1% through 2030.

The details: - Patient monitoring devices continuously track vital signs and alert healthcare providers to changes in a patient's condition. - The devices measure heart rate, blood pressure, oxygen saturation and respiratory rate. - The report links recent market growth to rising hospitalization rates, more chronic illness, ICU expansion, greater use of electronic health records and the need for continuous monitoring. - The analysis says home-based patient monitoring systems, telehealth infrastructure, connected healthcare ecosystems, preventive healthcare and real-time analytics are supporting longer-term growth. - Forecast trends include wider adoption of remote patient monitoring, more wearable vital signs devices, more continuous monitoring in critical care and greater use of AI-powered alert systems for early diagnosis. - Asia-Pacific held the largest share of the market in 2025. - North America ranked second in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report also offered a free sample and full market report online: More information and the full report.

Between the lines: - Chronic disease prevalence is a major demand driver because long-term conditions require ongoing observation and faster clinical response. - The World Health Organization said in February 2024 that over 35 million new cancer cases are expected worldwide by 2050, up 77% from about 20 million in 2022. - That disease burden is increasing pressure on health systems to use monitoring devices more broadly across hospitals and home care. - The regional split suggests Asia-Pacific's healthcare buildout and population growth are currently outpacing other markets, while North America's advantage remains tied to mature technology adoption.

What's next: - The market is expected to keep expanding as telehealth, remote monitoring and connected-care platforms gain more traction. - Adoption should rise further if hospitals and home-care providers continue adding real-time analytics and AI-based alert tools. - The report said its 2026 editions include new features such as market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards and market hotspot graphics.

The bottom line: - Patient monitoring is shifting from a hospital tool to a broader care platform, and the market forecast shows that transition still has room to run.